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Primary pulmonary tuberculosis (TB) in children typically 
forms a Ghon complex visible on the chest radiograph 
as perihilar or paratracheal lymphadenopathy with or 
without an area of parenchymal infiltrate (Ghon fo-
cus). Cavitation or breakdown of lung parenchyma is 
significantly more common in HIV-infected than HIV-
uninfected children. The determinants of cavitation in 
children are not well defined. In adults, cavitary disease 
is common and is thought to be due to a delayed hy-
persensitivity response to the TB bacilli. New or worsen-
ing cavitation has been described as a presenting fea-
ture of TB-related immune reconstitution inflammatory 
syndrome (TB-IRIS) in adults after starting highly active 
antiretroviral therapy (HAART). 
We present a case of cavitation of the Ghon focus in a 7-
month-old girl started on HAART at 2 months of age. We 
explore the pathogenesis of her cavitation, particularly 
focusing on two possibilities: an exaggerated immune 
response such as TB-IRIS, or an inadequate immune re-
sponse due to incomplete immune reconstitution.
Case report
The patient’s mother was identified as HIV-infected 
through participation in the Prevention of Mother to 
Child Transmission Program in the Western Cape, South 
Africa. Despite the mother having received antena-
tal zidovudine (ZDV) for 4 weeks, the infant’s HIV DNA 
polymerase chain reaction (PCR) test was positive at 6 
weeks of age. The viral load at that time was 43 200 
(log 4.64) copies per ml. The infant received HAART (ZDV, 
lamivudine and lopinavir/ritonavir) from 8 weeks of age 
through participation in the Children with HIV Early 
Antiretroviral therapy (CHER) trial. Compliance was con-
firmed with monthly pharmacy calculations. The base-
line CD4 count was 908 cells/μl (CD4% 22.9%), rising to 
1 214 cells/μl (31.4%) after 3 months on HAART. 
Five months after initiating HAART (i.e. at 7 months of 
age) the patient was hospitalised for an acute respira-
tory illness. Although she had no known TB contact, 
her weight had dropped significantly over the preced-
ing month (Fig. 1). Her CD4 count had dropped acutely 
to 762 cells/μl (23.6%). A chest radiograph showed hi-
lar lymphadenopathy with left lower lobe opacifica-
tion, and a single large cavity in the same region (Fig. 
2). These changes were not present on baseline chest 
radiographs done at 2 months of age.  Mycobacterium 
tuberculosis, fully susceptible to isoniazid and rifampicin, 
was cultured from a gastric aspirate. She was started on 
a standard three-drug TB regimen (isoniazid, rifampicin 
and pyrazinamide) with additional ritonavir added to her 
antiretroviral treatment, and thereafter displayed good 
catch-up growth (Fig. 1). A plasma HIV RNA level done at 
14 months of age was below detectable limits, confirm-
ing adherence to HAART. The left lower lobe cavity had 
resolved completely after 9 months of TB treatment (i.e. 
at 16 months of age). 
DisCussion 
The subject’s immune reconstitution had been reason-
ably successful. Three months after starting HAART (i.e. 
at 5 months of age) her CD4 count had risen from a 
baseline of 908 cells/μl (22.9%) to 1 214 cells/μl (31.4%), 
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Tuberculosis immune reconstitution inflammatory syndrome (IRIS) may present as new or worsening cavitation. 
We present an HIV-infected infant in whom TB infection and subsequent cavitation of the Ghon focus appeared 
to coincide with immune reconstitution due to highly active antiretroviral therapy (HAART). TB-IRIS in response to 
infection that occurs after starting HAART has not previously been described. 
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equivalent to the fifth centile for absolute CD4 counts 
among healthy black HIV-negative children between 3 
and 6 months of age in Europe (1 200 cells/μl).1 However, 
it is possible that her immune response may have been 
marginally impaired since, although at the lower limit 
of normal, her absolute CD4 count was well below the 
median for age (2 500 cells/μl).  
The clinical evidence in this case suggests that TB infec-
tion occurred after the initiation of HAART. According to 
the growth curve, failure to thrive began 1 month be-
fore presentation (i.e. 4 months after the initiation of 
HAART). Wallgren documented that the development of 
the hypersensitivity response to TB in normal children 
(as shown by a positive tuberculin skin test or erythema 
nodosum) and the clinical manifestations of primary TB 
occur between 5 and 6 weeks after infection, although 
in exceptional cases, this may occur up to 8 weeks after 
infection.2 Therefore, according to Wallgren’s ‘timetable 
of tuberculosis’ it is very unlikely that the manifestation 
of primary TB would have been delayed by 4 months. 
In adults, new or worsening cavitation may be a pre-
senting feature of TB-IRIS. Antimycobacterial activity 
is usually restored within 6 months of HAART in highly 
immunocompromised HIV-infected children.3 Conse-
quently, clinical deterioration due to TB-IRIS generally 
occurs within 6 months of starting HAART.3 In this case, 
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Fig. 1. Growth chart.
Fig. 2. Anteroposterior chest radiograph at 7 months of age.
cavitation of the.indd   46 3/16/09   2:18:23 PM
S UMMER  2 0 0 9                                                           T H E  S O U T H E R N  A F R I C A N  J O U R NA L  O F  H I V  M E D I C I N E 
symptoms began 4 months after starting HAART. This 
case satisfied the paediatric IRIS working group consen-
sus criteria for the diagnosis of TB-IRIS in children.4 Cur-
rently two forms of TB-IRIS have been described: acute 
unmasking of pre-existing TB infection, and paradoxical 
worsening of known pulmonary TB disease.4  Both ‘un-
masking’ and ‘paradoxical’ IRIS occur in response to TB 
bacilli present in the lung parenchyma before the initia-
tion of HAART. 
The pathogenesis of IRIS is poorly understood but is 
related to the recovery of the Th-1 immune response 
following successful suppression of viral replication by 
HAART.5 The newly reconstituted Th-1 system then reacts 
aggressively to antigens of dead and living organisms 
accumulated during immune suppression. This exagger-
ated (or possibly dysregulated) immune response causes 
local tissue damage, resulting in the typical manifesta-
tions of IRIS. There is some evidence that the recovery 
of M. tuberculosis-specific Th-1 cells occurs more slowly 
than the recovery of other specific Th-1 responses.6 This 
may result in a delay in the manifestation of TB-IRIS af-
ter the initiation of HAART. 
In our case, TB infection most likely occurred after the 
initiation of HAART. Therefore our case cannot definitive-
ly be included in either the paradoxical or the unmasking 
category of TB-IRIS. We question whether this case may 
represent a third, previously unrecognised form of TB-
IRIS where exposure to a new pathogen may result in 
an exaggerated immunological response due to dysregu-
lated immune recovery in the early phase of HAART. In 
young infants, it is possible that prior exposure to bacille 
Calmette-Guérin immunisation at birth may prime the 
immune system for an IRIS-like response on exposure to 
M. tuberculosis during the early phase of HAART.3
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The South African Red Cross shows a Siyayinqoba educational video about TB and HIV to a family in Khatlehong. There are eight 
people living in the home. Their father died of TB last year after being infected for the third time. The daughter currently has MDR-
TB and is on antiretrovirals. She was bedridden but is starting to feel better and able to walk around the house. Her brother is also 
showing symptoms of TB, and during this visit the Red Cross managed to convince him to be tested.
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